Results 161 to 170 of about 20,878 (216)

Evaluation of Cardiotoxicity in Lymphoproliferative Patients Treated With Anthracycline and Bruton's Tyrosine Kinase Inhibitor-Based Regimens. [PDF]

Cureus
Bonsu A.
europepmc   +1 more source

Real-world treatment patterns of Bruton tyrosine kinase inhibitors in mantle cell lymphoma in a community oncology setting. [PDF]

Future Oncol
Shah BD, Xue M, Furnback W, Yang K.
europepmc   +1 more source

Outcomes following exposure to drug interactions with ibrutinib in patients with chronic lymphocytic leukaemia. [PDF]

Br J Haematol
Hoang T, Cheung MC, Juurlink DN, Chan KKW, Lau C, Liu N, Abdel-Qadir H, Prica A, Hay AE, Vijenthira A, Mozessohn L.   +10 more
europepmc   +1 more source

Commentary on “real world results of ibrutinib in patients with relapsed or refractory chronic lymphocytic leukemia: a meta-analysis of clinical studies” [PDF]

Ali Beheshti Namdar, Masoud Keikha
openalex   +1 more source

EHA-EU MCL network guidelines for diagnosis and treatment of mantle cell lymphoma. [PDF]

Hemasphere
Jerkeman M, Aurer I, Campo E, Cheah CY, Clark J, Doorduijn J, Eyre TA, Fehr M, Giné E, Gomes da Silva M, Klener P, Ladetto M, Ribrag V, Shpilberg O, Walewski J, Dreyling M, EHA Guidelines Committee and the European MCL Network.   +16 more
europepmc   +1 more source

Zanubrutinib in the treatment of Waldenström Macroglobulinemia. [PDF]

Future Oncol
Goodall E, Opat S.
europepmc   +1 more source

The Combination of Ibrutinib with BH3 Mimetics or Dichloroacetate Is Effective in B-CLL. [PDF]

Cells
Marco-Brualla J, Gonzalo O, Azaceta G, Izquierdo I, Palomera L, Villalba M, Marzo I, Anel A.   +7 more
europepmc   +1 more source

<i>Aspergillus</i> Endocarditis: A Rare but Serious Complication During Treatment With Ibrutinib. [PDF]

Case Rep Infect Dis
Mezzadri L, Caramma IGC, Sciabica IM, Migliorino GM, Cavallero A, Marchetto G, Lapadula G, Bonfanti P.   +7 more
europepmc   +1 more source

Ibrutinib inhibits the replication of multiple poxviruses by targeting the Bruton tyrosine kinase. [PDF]

J Virol
Niu K, Wang X, Jiang Q, Liu K, Xie S, Song B, Wu W, Li X, Peng C.   +8 more
europepmc   +1 more source

Tolerability and long-term disease control by IGHV mutation status among patients with CLL on ibrutinib arm of E1912 [PDF]

Tait D. Shanafelt, Victoria Wang, Curtis A. Hanson, Elisabeth Paietta, Susan O’Brien, Jacqueline C. Barrientos, Diane F. Jelinek, Esteban Braggio, José F. Leis, Cong Christine Zhang, Paul M. Barr, Amanda F. Cashen, Anthony R. Mato, Avina K. Singh, Michael P. Mullane, Richard F. Little, Harry P. Erba, Richard M. Stone, Mark R. Litzow, Martin S. Tallman, Neil E. Kay   +20 more
openalex   +1 more source